Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Counterpart Ventures is a venture capital firm based in San Francisco that specializes in early-stage investments, particularly in B2B SaaS, mobility, and marketplace sectors. A key differentiator for the firm is its management of the JSR Life Sciences Corporate Venture Fund, which focuses on identifying and supporting innovative biotechnology and life science startups. By bridging the gap between traditional venture capital and corporate strategic interests, Counterpart Ventures provides its portfolio companies with both financial capital and deep industry expertise. The firm was founded by Patrick Eggen and Joe Saijo, both of whom have extensive backgrounds in corporate venture capital. Their investment approach is data-driven, aiming to modernize the enterprise through strategic partnerships and operational support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Counterpart Ventures.